This report is Bluesight®’s first-ever analysis of ControlCheck™ data from 2020-2022. This data includes quarter-over-quarter trends and deep insights into everything until the end of Q4 2021. Bluesight analyzed 2+ years’ worth of data, including 50M+ controlled substance transactions, from our ControlCheck drug diversion platform. We’re sharing this data to provide insight into the emerging trends, as well as the types of diversions and investigations that may be occurring in your hospitals. Data is accurate as of December 31st, 2021